F C Richardson - JoVE Visualize

Showing results (31-40 of 41) with videos related to

Pageof 5

Sort By:

Electrophoresis|January 1, 1993

Comparisons of protein changes in human and rodent hepatocytes induced by the rat-specific carcinogen, methapyrileneF C Richardson, S C Strom, D M Copple, et al.

Cancer Research|October 1, 1993

Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragmentW E Schy, L W Hertel, J S Kroin, et al.

Carcinogenesis|February 1, 1994

H-ras 61st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883L M Helvering, F C Richardson, D M Horn, et al.

Environmental Health Perspectives|December 1, 1987

High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substancesJ A Swenberg, F C Richardson, J A Boucheron, et al.

Carcinogenesis|June 1, 1992

Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986K K Richardson, L M Helvering, D M Copple, et al.

Cancer Letters|July 30, 1993

Expression of TRPM-2 during involution and regeneration of the rat liverL M Helvering, K K Richardson, D M Horn, et al.

Toxicologic Pathology|December 10, 1999

An evaluation of the toxicities of 2'-fluorouridine and 2'-fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax)F C Richardson, B C Tennant, D J Meyer, et al.

Nucleic Acids Research|November 1, 1996

Differential effects of the incorporation of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) on the binding of the transcription factors, AP-1 and TFIID, to their cognate target DNA sequencesK A Staschke, K K Richardson, T E Mabry, et al.

Anti-Cancer Drugs|April 6, 2001

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing miceJ P Desjardins, E A Abbott, D L Emerson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.

Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:

Pageof 5

Electrophoresis|January 1, 1993

Comparisons of protein changes in human and rodent hepatocytes induced by the rat-specific carcinogen, methapyrileneF C Richardson, S C Strom, D M Copple, et al.

Cancer Research|October 1, 1993

Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragmentW E Schy, L W Hertel, J S Kroin, et al.

Carcinogenesis|February 1, 1994

H-ras 61st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883L M Helvering, F C Richardson, D M Horn, et al.

Environmental Health Perspectives|December 1, 1987

High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substancesJ A Swenberg, F C Richardson, J A Boucheron, et al.

Carcinogenesis|June 1, 1992

Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986K K Richardson, L M Helvering, D M Copple, et al.

Cancer Letters|July 30, 1993

Expression of TRPM-2 during involution and regeneration of the rat liverL M Helvering, K K Richardson, D M Horn, et al.

Toxicologic Pathology|December 10, 1999

An evaluation of the toxicities of 2'-fluorouridine and 2'-fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax)F C Richardson, B C Tennant, D J Meyer, et al.

Nucleic Acids Research|November 1, 1996

Differential effects of the incorporation of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) on the binding of the transcription factors, AP-1 and TFIID, to their cognate target DNA sequencesK A Staschke, K K Richardson, T E Mabry, et al.

Anti-Cancer Drugs|April 6, 2001

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing miceJ P Desjardins, E A Abbott, D L Emerson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.

Pageof 5